DPP-4 inhibitors like Onglyza, Januvia, Tradjenta, and Nesina need to be “readdressed” by the FDA as they are proven to be associated with an increased death rate.
DPP-4 inhibitors are prescribed for type 2 diabetes; they were very quickly studied, quickly obtained FDA approval, and were quickly distributed via prescription to millions of people.
After the fact Onglyza, Tradjenta, Januvia, and Nesina have been linked to diseases like pancreatic cancer, bladder cancer, liver cancer, and kidney cancer.…People are dying from using these medications and the FDA doesn’t even know why they are killing people.. Imagine that.
TAKE A STAND
ENOUGH! I can’t take this anymore and you shouldn’t either. We are being prescribed toxic medications that have been improperly tested ….and these prescription drugs are literally killing us.
Over 65% of the US adult population has metabolic issues.
IF THE FOLLOWING PARAGRAPH DESCRIBES YOU, DON’T ADD ANY NEW MEDICATIONS UNTIL YOU TAKE CONTROL OF YOUR BODY AND METABOLISM
If you have…
View original post 865 more words